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Lymphogranuloma venereum, caused by the L serovars of Chlamydia 
trachomatis, emerged in Europe in 2003 and a series of outbreaks 
were reported in different countries. The infection presents as a 
severe proctitis in men who have sex with men, many of whom are 
co-infected with HIV and other sexually transmitted infections. 
This paper reviews the number of cases reported over a five year 
period, from 2003 to 2008, from countries that were part of the 
European Surveillance of Sexually Transmitted Infections (ESSTI) 
network. Reports were received from Belgium, Denmark, France, 
Germany, the Netherlands, Portugal, Spain, Sweden, and the 
United Kingdom. It appears that after five years the characteristics 
of the patients infected has overall remained unchanged, although 
the total number of cases has increased and more countries in 
Europe have now identified cases of LGV.
Introduction
After initial case reports in late 2003, an outbreak of 
lymphogranuloma venereum (LGV) among men who have sex with 
men (MSM) was described in the Netherlands in 2004 [1-3]. MSM 
with LGV have presented with severe proctitis, the majority were 
co-infected with HIV and other sexually transmitted infections (STI) 
such as Hepatitis C, and reported unprotected anal intercourse 
[2-5]. Prior to 2003, LGV had been unusual in Western Europe 
for many years with most cases being imported. Classically, 
LGV presents as genital ulceration with lymphadenopathy and a 
secondary anorectal syndrome in tropical and subtropical countries 
in Africa, Asia, Central and South America [6]. The causative agent 
of LGV is Chlamydia trachomatis belonging to the L serovars and the 
current outbreak in Europe has been almost exclusively attributed 
to L2 genotype. 
LGV was not a notifiable disease in many countries but enhanced 
surveillance has been established since 2004 in the Netherlands 
(January) and the United Kingdom (UK, October), and sentinel 
surveillance was set up in Germany (May).  France introduced 
sentinel surveillance in January 2005 while LGV reporting in Sweden 
was performed via the mandatory Chlamydia laboratory reporting 
system since 2004. Other EU Member States did not change their 
national STI notification systems and LGV cases were reported 
through routine clinical or laboratory observations. From June 
2003, the European Surveillance of Sexually Transmitted Infections 
(ESSTI) network enabled epidemiologists and microbiologists to 
communicate, share information and raise alerts on emerging 
STI or outbreaks of STI via ESSTI_ALERT. This platform was also 
used to disseminate information about LGV. This report collates 
data collected through the ESSTI network and comments on the 
situation regarding LGV five years on from the apparent start of the 
outbreak in 2003.
Methods
In June 2008, the focal points of 24 countries participating 
in the ESSTI network were asked to provide information on LGV 
since 2003 for their respective countries (by short questionnaire). 
Countries were asked to provide available data on: monthly/
quarterly number of cases, their sexual orientation, HIV status, 
age, sex, concurrent STI, travel abroad, clinical syndrome i.e. ano-
rectal or inguinal, clinical symptoms, number of sexual partners in 
the last three months, and any other information available which 
they felt was relevant.  Where no data or only incomplete data was 
available, information was compiled from reports of LGV submitted 
to ESSTI_ALERT during 2004 and 2008. 
The ESSTI_ALERT system was developed as an informal system 
for epidemiologists and microbiologists to facilitate sharing and 
dissemination of early information on unusual events or outbreaks 
of STI across Europe. The system is based on a monthly active 
notification of unusual STI transmission events to the ESSTI 
coordinating centre meaning that notifications were requested 
actively each month from the coordination centre and were made 
using a standard reporting form.
Results
Nine countries (Belgium, Denmark, France, Germany, the 
Netherlands, Portugal, Spain, Sweden and the UK) provided data 
on LGV cases. For three additional countries: Ireland, Italy, and 
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Norway information was compiled using ESSTI alerts from 2007 
and 2008. 
Trends
From 2002 to 2007, the total number of cases reported was 
1,693 (the UK 648 cases, France 556, the Netherlands 255, 
Germany 159, Belgium 45, Denmark 18, Portugal 8, Spain 4). LGV 
cases were already reported between 2002 and 2004 in Belgium, 
the UK, France, the Netherlands and Germany from where cases 
continued to be diagnosed. The highest number of cases was 
reported in the third quarter of 2005 with 96 cases diagnosed 
in the UK.  The number of cases in the UK declined in 2006 but 
increased again in 2007 (Figure 1) and 2008 (191 cases) (data 
not shown). The Netherlands also saw an increase in the number 
of LGV cases reported starting towards the end of 2006. In France, 
the number of cases increased each year since 2002 until 2007 
and seemed stable in 2008 with 170 and 174 cases respectively. 
Denmark, Portugal and Spain - countries that had not seen LGV 
cases early in the outbreak - started to report cases in 2006 and 
2007 (Figure 2).
Characteristics
Characteristics of recent cases were similar to those in early 
outbreak reports. LGV cases were predominantly found among 
MSM with between 80-100% of cases in all countries reporting, 
except for Portugal (Table 1). In France, information on sexual 
orientation is not available; however, all French cases were male and 
C. trachomatis serovar L2 was identified from anorectal samples. 
The majority of the European cases were co-infected with HIV, 
with the proportion of HIV-positives ranging from 40% in one 
sentinel site in Spain (Bilbao) to 100% in Sweden (Table 1).  
Data on concurrent infections other than HIV was available from 
Belgium, Denmark, the Netherlands, Portugal, Spain (Bilbao), and 
the UK (Table 1). For gonorrhoea the proportion ranged from 0% in 
Portugal to 25% in the Netherlands and for syphilis co-infections 
the range was between 6% in the UK where a large number of LGV 
cases had been detected, to 40% in Portugal.
 
The clinical presentation was anorectal syndrome in the majority 
of cases: all cases in Netherlands, both cases in Portugal where the 
clinical syndrome was known, and 31 out of 36 cases in Denmark. 
Thirty-eight of 45 cases in Belgium had proctitis. In six cases, LGV 
was reported as inguinal manifestation (Denmark 5 cases, Spain 
1 case). 
LGV was mostly diagnosed in MSM aged above 25 years, with 
the exception of an outbreak in Catalonia where 25 of 28 cases of 
LGV were in MSM younger than 25 years (Table 1). High numbers 
of sexual partners were noted for cases in Spain, with more than 
20 partners in the last six months reported for three of five cases; 
while more than five partners in the last six months were reported 
for eight of 15 cases in Belgium. 
Only few male heterosexual cases were reported: two in Portugal, 
one in Spain (female partner also infected), and three in the UK. 
In Germany, cases were reported without additional information 
on sexual orientation.
Reports to ESSTI_ALERT
Reports to ESSTI-ALERT were received from Ireland; two LGV 
cases, both MSM, one HIV-positive; from Italy, three cases, all 
MSM, two of whom were HIV-positive; and from Norway, four cases, 
without additional information. These reports, however, do not 
necessarily represent the total number detected in each of these 
countries. Sweden described an LGV cluster of five cases with 
domestic transmission in a sexual network in Stockholm . 
Discussion
From 2003 to 2008 the number of reported cases of LGV has 
increased in different countries in Europe, with the largest numbers 
reported in the UK, France, the Netherlands and Germany [7-
10].  Moreover, since 2006 LGV has been reported in additional 
countries including Italy, Austria, Denmark, Portugal and Spain 
although often with a small total number of cases [11-15]. The 
profile of infected individuals, MSM with proctitis over 25 years of 
age and predominantly co-infected with HIV, has remained largely 
unchanged throughout the epidemic. Only some exceptions were 
reported, such as a small number of heterosexual cases detected by 
systematic screening in Portugal, with only few cases in total [14]. 
In the UK, where over 800 cases were detected, 13 presented with 
unusual clinical features: five cases of urethral LGV, three cases of 
LGV-associated inguinal buboes, one case of a solitary LGV penile 
ulcer and another case with a penile ulcer and bubonulus [16]. A 
case of bubonulus has also been reported from France [17]. 
The number of LGV cases continued to increase in several 
European countries and the characteristics of the patients appear 
to have remained unchanged, despite a few exceptions. Countries 
have reported actively on the number of cases detected, however, 
the reporting is largely influenced by the existence of a national 
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sentinel surveillance system for LGV and the active case finding 
practices in clinical care across and within countries. The LGV 
cases presented here are probably largely underestimated due to 
the fact that cases may not be recognised, remain undiagnosed or 
are not reportable to national surveillance systems. Furthermore, 
ESSTI_ALERTS have increased awareness throughout the network 
but did not involve clinicians in the participating countries. Another 
weakness in our data and in the literature is a lack of a consistent 
case definition across Europe and the lack of LGV genotyping in 
some countries particularly early in the outbreak. Nevertheless, the 
consistency in the characteristics of patients infected with LGV 
across Europe suggests that this is a distinct entity.
There is little evidence that the LGV outbreak in MSM has spread 
to a wider population since 2003. LGV still seems to occur amongst 
a core group of individuals infected with HIV and with high-risk 
sexual behaviour [18-20]. The low number of cases among HIV-
negative and heterosexual men indicates little bridging between 
the core MSM and other sexual networks. Molecular typing studies 
have shown that, where the data is available, the infecting LGV 
strain belongs primarily to serovar L2b [21] and although variants 
have been found, these differ from the parent strain by only a few 
base pairs [22]. This seems to point towards transmission within 
a closed network but data needs to be interpreted with caution as 
the molecular typing methods are poorly discriminatory at present. 
Spaargaren et al. [21] compared strains from the current European 
outbreak with strains collected in the 1980s in the United States 
and found both belonging to serovar L2b. The conclusion from 
this might be that the outbreak has not emerged recently but may 
rather have gone undetected due to the lack of specific screening 
for LGV genotypes.
The reasons for the re-emergence of LGV in Europe over the last 
five to six years remain unclear and it has been suggested that it 
is the result of the increased availability of molecular diagnostic 
tests [23]. While there has certainly been considerable development 
[24-27] and increased use of molecular tests to directly detect 
C. trachomatis belonging to the L serovars [28], this appears to 
have been largely in response to a clinical need [29]. There do 
remain a number of elusive questions regarding the reservoir and 
mode of transmission that perpetuates the ongoing outbreak. Data 
regarding the existence of an asymptomatic reservoir are conflicting 
with only a small number of asymptomatic cases detected in the 
UK compared to a larger number in the Netherlands [28,30-32], 
although this may simply reflect variation in protocols for screening 
and testing of MSM patients across Europe. The inability to detect 
C. trachomatis serotypes causing LGV in the urethra points at 
possible transmission through inanimate objects such as sex toys, 
or the inability of the pathogen to colonise the urethra. High-risk 
behaviour is now well documented as a characteristic of individuals 
infected with LGV but the use of enemas and increased number of 
partners are the only risk factors currently identified [22]. There 
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is other epidemiological evidence that STI such as syphilis and 
resistant gonorrhoea are increasing in MSM in many countries, 
showing that STI infections can spread in sexual networks of MSM 
across Europe [33].
Sharing of information through the ESSTI has raised awareness 
for the problem of LGV in MSM. However, cases continue to be 
detected in many European countries, implying that control and 
prevention strategies which have so far concentrated on accurate 
diagnosis and treatment of cases and their sexual partners, have not 
been optimal. Activities also included raising awareness amongst 
healthcare professionals and the gay community in some countries. 
This is in contrast to the situation which occurred in the late 
1990s when outbreaks of syphilis were first reported in Western 
Europe among MSM. A variety of control measures targeting 
MSM were introduced by countries such as health education and 
promotion, increased clinic capacity, syphilis screening at social 
venues and clinics and at HIV treatment centres, distribution of 
free condom packs, and contact tracing [34]. Despite all these 
efforts, syphilis rates have reached high levels almost equal to 
the pre-AIDS era in many countries. Although the numbers of 
LGV remain small in comparison to the number of syphilis cases 
reported, it is clear that LGV is becoming endemic in particular 
sexual networks and alternative approaches to the control of LGV 
should possibly be considered. Surveillance and monitoring of LGV 
is currently implemented at EU level by the European Centre for 
Disease Prevention and Control (ECDC) as part of the enhanced 
surveillance for STI as agreed with the Member States. Reporting to 
one European surveillance system shall contribute to the availability 
of more comparable data on LGV, and STI in general, in the future.
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